S. Sperl
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms
Papers in
-
- Protease and Inhibitor Mechanisms 13
- Hematology 12
- Blood Coagulation and Thrombosis Mechanisms 12
- Co-authors
- Viktor Magdolen (12 shared papers)Manfred Schmitt (10 shared papers)Jörg Stürzebecher (7 shared papers)Olaf G. Wilhelm (6 shared papers)Achim Krüger (6 shared papers)Nadia Harbeck (2 shared papers)Ute Reuning (4 shared papers)Bernd Muehlenweg (3 shared papers)
- Journals
- Biological Chemistry (3 papers)Advances in experimental medicine and biology (1 paper)Expert Opinion on Biological Therapy (1 paper)European Journal of Biochemistry (1 paper)Journal of Molecular Biology (1 paper)
- Partner nations
- Germany
In The Last Decade
S. Sperl
15 papers receiving 470 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 336
- Hematology 185
- Immunology and Allergy 94
- Genetics 77
- Oncology 184
Countries citing papers authored by S. Sperl
This map shows the geographic impact of S. Sperl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Sperl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Sperl more than expected).
Fields of papers citing papers by S. Sperl
This network shows the impact of papers produced by S. Sperl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Sperl. The network helps show where S. Sperl may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Sperl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 101 | |
| 2 | 2000 | 63 | |
| 3 | 2000 | 58 | |
| 4 | 2001 | 54 | |
| 5 | 2003 | 52 | |
| 6 | 2002 | 42 | |
| 7 | 2002 | 32 | |
| 8 | 2001 | 21 | |
| 9 | 2005 | 16 | |
| 10 | 2003 | 16 | |
| 11 | 2002 | 14 | |
| 12 | 2002 | 11 | |
| 13 | Natural inhibitors of tumor-associated proteases | 2002 | 10 |
| 14 | 2000 | 6 | |
| 15 | The urokinase-type plasminogen activator (uPA) system - A new target for tumor therapy | 2002 | 4 |
About S. Sperl
S. Sperl is a scholar working on Cancer Research, Hematology, Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 500 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (13 papers), Blood Coagulation and Thrombosis Mechanisms (12 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Peptidase Inhibition and Analysis (6 papers), Blood properties and coagulation (1 paper), Venomous Animal Envenomation and Studies (1 paper), Vitamin K Research Studies (1 paper) and Enzyme Structure and Function (1 paper). The work is most often cited by research in Cancer Research (336 citations), Hematology (185 citations), Immunology and Allergy (94 citations), Genetics (77 citations) and Oncology (184 citations). S. Sperl has collaborated with scholars based in Germany. Frequent co-authors include Viktor Magdolen, Manfred Schmitt, Jörg Stürzebecher, Olaf G. Wilhelm, Achim Krüger, Nadia Harbeck, Ute Reuning, Bernd Muehlenweg, Horst Kessler and Luis Moroder. Their work appears in journals such as Biological Chemistry, Advances in experimental medicine and biology, Expert Opinion on Biological Therapy, European Journal of Biochemistry and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.